Pioglitazone Attenuates Ischemia/Reperfusion-Induced Liver Injury in Rats

Transplantation Proceedings

Volumn 41, Issue 10, 2009, Pages 4105-4109

  Somi, M H ^a   Hajipour, B ^b   Asl, N A ^a   Estakhri, R ^a   Azar, A N ^b   Zade, M N ^b   Haghjou, A G ^c   Vatankhah, A M ^d  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GLUTATHIONE PEROXIDASE; LIVER ENZYME; MALONALDEHYDE; PIOGLITAZONE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL DEGENERATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HISTOPATHOLOGIC SKIN REACTION; LIVER; LIVER CELL; LIVER INJURY; LIVER ISCHEMIA; LIVER PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; REPERFUSION INJURY; SHAM PROCEDURE; WISTAR RAT;

ANIMALS; ANTI-BACTERIAL AGENTS; GLUTATHIONE PEROXIDASE; LIVER; MALE; MALONDIALDEHYDE; RATS; RATS, WISTAR; REPERFUSION INJURY; SUPEROXIDE DISMUTASE; THIAZOLIDINEDIONES;

EID: 71249120763     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.09.075     Document Type: Article

References (34)

1. Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol 284 (2003) 15
2. Shen S.Q., Zhang Y., Xiang J.J., et al. Protective effect of curcumin against liver warm ischemia/reperfusion injury in rat model is associated with regulation of heat shock protein and antioxidant enzymes. World J Gastroenterol 13 (2007) 1953
3. Colletti L.M., Remick D.G., Burtch G.D., et al. Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest 85 (1990) 1936
4. Suzuki S., and Toledo-Pereyra L.H. Interleukin 1 and tumor necrosis factor production as the initial stimulants of liver ischemia and reperfusion injury. J Surg Res 57 (1994) 253
5. Okuaki Y., Miyazaki H., Zeniya M., et al. Splenectomy-reduced hepatic injury induced by ischemia/reperfusion in the rat. Liver 16 (1996) 188
6. Jaeschke H., and Mitchell J.R. Mitochondria and xanthine oxidase both generate reactive oxygen species after hypoxic damage in isolated perfused rat liver. Biochem Biophys Res Commun 160 (1989) 140
7. Kumamoto Y., Suematsu M., Shimazu M., et al. Kupffer cell-independent acute hepatocellular oxidative stress and decreased bile formation in post-cold ischemic rat liver. Hepatology 30 (1999) 1454
8. Li J.M., and Shah A.M. Differential NADPH- versus NADH dependent superoxide production by phagocyte-type endothelial cell NADPH oxidase. Cardiovasc Res 52 (2001) 477
9. Lee W.Y., Lee J.S., and Lee S.M. Protective effects of combined ischemic preconditioning and ascorbic acid on mitochondrial injury in hepatic ischemia/reperfusion. J Surg Res 142 (2007) 45
10. Pereira M.G., Câmara N.O., Campaholle G., et al. Pioglitazone limits cyclosporine nephrotoxicity in rats. Int Immunopharmacol 6 (2006) 1943
11. Chinetti G., Fruchart J.C., and Staels B. Peroxisome proliferator-activated receptors and inflammation: from basic science to clinical applications. Int J Obes Relat Metab Disord 27 (2003) 41
12. Berger J., and Moller D.E. The mechanisms of action of PPARs. Annu Rev Med 53 (2002) 409
13. Xu P., Zhou X.J., Chen L.Q., et al. Pioglitazone attenuates the severity of sodium taurocholate-induced severe acute pancreatitis. World J Gastroenterol 13 (2007) 1983
14. Ito K., Shimada J., Kato D., et al. Protective effects of preischemic treatment with pioglitazone, a peroxisome proliferator-activated receptor-gamma ligand, on lung ischemia-reperfusion injury in rats. Eur J Cardiothorac Surg 25 (2004) 530
15. Quinones J., Pampaloni M.H., Juarez B.E., et al. Insulin resistance in healthy Mexican Americans is associated with coronary artery endothelial dysfunction. Diabetes 49 (2000) 146
16. Haraguchi G., Kosuge H., Maejima Y., et al. Pioglitazone reduces systematic inflammation and improves mortality in apolipoprotein E knockout mice with sepsis. Intensive Care Med 34 (2008) 1304
17. Ceriello A. Thiazolidinediones as anti-inflammatory and anti-atherogenic agents. Diabetes Metab Res Rev 24 (2008) 14
18. Inoue I., Goto S., Matsunaga T., et al. The ligands/activators for peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma increase Cu2+,Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells. Metabolism 50 (2001) 3
19. Shimazu T., Inoue I., Araki N., et al. A peroxisome proliferator-activated receptor-gamma agonist reduces infarct size in transient but not in permanent ischemia. Stroke 36 (2005) 353
20. Schmerbach K., Schefe J.H., Krikov M., et al. Comparison between single and combined treatment with candesartan and pioglitazone following transient focal ischemia in rat brain. Brain Res 1208 (2008) 225
21. Jiang H., Meng F., Li W., et al. Splenectomy ameliorates acute multiple organ damage induced by liver warm ischemia reperfusion in rats. Surgery 141 (2007) 32
22. Paglia D.E., and Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70 (1967) 158
23. Paoletti F., Aldinucci D., Mocali A., et al. A sensitive spectrophotometric method for the determination of superoxide dismutase activity in tissue extracts. Anal Biochem 154 (1986) 536
24. Kaya H., Sezik M., Ozkaya O., et al. Lipid peroxidation at various estradiol concentrations in human circulation during ovarian stimulation with exogenous gonadotropins. Horm Metab Res 36 (2004) 693
25. Draper H.H., and Hadley M. Malonaldehyde determination as index of lipid peroxidation. In: Parcker L., and Glazer A. (Eds). Methods in Enzymology 186 (1991) 421
26. McCord J.M. The evolution of free radicals and oxidative stress. Am J Med 108 (2000) 652
27. Friedman S.L. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 275 (2000) 2247
28. Allaouchiche B., Debon R., Goudable J., et al. Oxidative stress status during exposure to propofol, sevoflurane and desflurane. Anesth Analg 93 (2001) 981
29. Huang S.Z., Luo Y.J., Wang L., et al. Effect of ginkgo biloba extract on livers in aged rats. World J Gastroenterol 11 (2005) 132
30. Baltalarli A., Ozcan V., Bir F., et al. Ascorbic acid (vitamin C) and iloprost attenuate the lung injury caused by ischemia/reperfusion of the lower extremities of rats. Ann Vasc Surg 20 (2006) 49
31. Goldfarb A.H., McIntosh M.K., and Boyer B.T. Vitamin E effects on indexes of lipid peroxidation in muscle from DHEA-treated and exercised rats. J Appl Physiol 76 (1994) 1630
32. Langdale L.A., Hoagland V., Benz W., et al. Suppressor of cytokine signaling expression with increasing severity of murine hepatic ischemia-reperfusion injury. J Hepatol 49 (2008) 198
33. Akahori T., Sho M., Hamada K., et al. Importance of peroxisome proliferator-activated receptor-gamma in hepatic ischemia/reperfusion injury in mice. J Hepatol 47 (2007) 784
34. Michalik L., and Wahli W. Involvement of PPAR nuclear receptors in tissue injury and wound repair. J Clin Invest 116 (2006) 598